Treatment was initiated at 36 mg/working day and patients continued with incremental boosts of 18 mg/working day (36 to 108 mg/day) determined by meeting particular advancement criteria with suitable tolerability. At the final review pay a visit to, indicate alter scores (LS Necessarily mean, SEM) to the investigator ranking within the AISRS demons